✦ LIBER ✦

Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy

✍ Scribed by Simon, N; Marsot, A; Villard, E; Choquet, S; Khe, H-X; Zahr, N; Lechat, P; Leblond, V; Hulot, J-S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose methotrexate population pharma

✍ Ye Min; Fu Qiang; Li Peng; Zhu Zhu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

Pharmacokinetics of Platinum in Cancer P

✍ Adnan El-Yazigi; Magid Amer; Cazemiro R. Martin 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 745 KB

Comparative pharmacokinetic study of hig

✍ Dorr, R T; Briggs, A; Kintzel, P; Meyers, R; Chow, H-HS; List, A 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

P0177 Impact of genetic polymorphisms of

✍ Suthandiram, S.; Gan, G.-G.; Mohd Zain, S.; Bee, P.-C.; Lian, L.-H.; Chang, K.-M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Population pharmacokinetics of high-dose

✍ K. Fukuhara; K. Ikawa; N. Morikawa; K. Kumagai 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

The role of MTHFR and RFC1 polymorphisms

✍ Patrizia Chiusolo; Sabrina Giammarco; Silvia Bellesi; Elisabetta Metafuni; Nicol 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 240 KB